Compare Edelweiss Business Cycle Fund vs Mahindra Manulife Business Cycle Fund
Edelweiss Business Cycle Fund
Mahindra Manulife Business Cycle Fund
Risk
Very High
Very High
Rating
-
-
Min SIP Amount
₹100
₹500
Expense Ratio
2.77
2.41
NAV
₹9.46
₹16.55
Fund Started
09 Jul 2024
21 Aug 2023
Fund Size
₹1463.37 Cr
₹1356.69 Cr
Exit Load
Exit load of 1%, if redeemed within 90 days.
Exit load of 1%, if redeemed within 3 months
1 Year
4.73%
8.43%
3 Year
-
-
5 Year
-
-
Equity
98.27%
97.24%
Cash
-0.24%
2.76%
Top 10 Holdings
Laurus Labs Ltd. | 4.19% |
Cummins India Ltd. | 3.64% |
Polycab India Ltd. | 3.46% |
State Bank of India | 2.77% |
Glenmark Pharmaceuticals Ltd. | 2.76% |
GE Vernova T&D India Ltd | 2.69% |
Muthoot Finance Ltd. | 2.41% |
The Federal Bank Ltd. | 2.34% |
Sun Pharmaceutical Industries Ltd. | 2.32% |
Fortis Healthcare Ltd. | 2.27% |
Reliance Industries Ltd. | 4.04% |
JSW Energy Ltd. | 3.25% |
ICICI Bank Ltd. | 3.17% |
Grasim Industries Ltd. | 3.09% |
Bajaj Auto Ltd. | 2.69% |
Indusind Bank Ltd. | 2.68% |
Axis Bank Ltd. | 2.58% |
Adani Enterprises Ltd. | 2.44% |
Indus Towers Ltd. | 2.31% |
Tech Mahindra Ltd. | 2.27% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity related securities with a focus on navigating business cycles through dynamic allocation between various sectors and stocks at different stages of business cycles in the economy. There is no assurance that the investment objective of the Scheme will be achieved.
The Scheme seek to generate long term capital appreciation by investing predominantly in equity and equity related securities with a focus on identifying and investing in business cycles through dynamic allocation between various sectors and stocks at different stages of business cycles in the economy.
Launch Date
09 Jul 2024
21 Aug 2023
